| 
		Asia's rising coronavirus cases a worry as vaccine doubts cloud 
		campaigns
		 Send a link to a friend 
		
		 [April 08, 2021] 
		Singapore (Reuters) - India, South 
		Korea and Thailand faced mounting coronavirus infections on Thursday, 
		undermining cautious hopes that Asia might be emerging from the worst of 
		the pandemic as worries about safety threatened to delay vaccination 
		drives. 
 India reported a record 126,789 new cases, the third day this week 
		tallies have surged to more than 100,000, catching by surprise 
		authorities who have blamed crowding and a reluctance to wear masks as 
		shops and offices reopen.
 
 More infectious variants of the virus may have played a role in India's 
		surge, some epidemiologists say, with hundreds of cases found of 
		variants first detected in Britain, South Africa and Brazil.
 
 The alarming numbers have led to New Zealand putting a temporary ban on 
		anyone arriving from India, even for the first time blocking New Zealand 
		citizens from coming home, for about two weeks.
 
 "We are temporarily suspending entry into New Zealand for travellers 
		from India," Prime Minister Jacinda Ardern told a news conference in 
		Auckland.
 
 New Zealand, which has virtually eliminated the virus within its 
		borders, recorded 23 new cases at its border on Thursday, 17 from India.
 
		
		 
		Two other countries that managed to largely keep the coronavirus under 
		control during the first year of the pandemic were also grappling with 
		new waves, though smaller than India's.
 South Korea reported 700 new cases on Thursday, its highest daily figure 
		since early January, and the prime minister warned that new social 
		distancing rules would likely be needed.
 
 Thailand, which has been planning a cautious re-opening of its tourist 
		industry, reported a rise in new daily infections to 405 on Thursday, 
		taking its total number of infections to 30,310, with 95 deaths.
 
 Adding to Thai worries, it has detected 24 cases of a highly contagious 
		virus variant first detected in Britain, its first reported domestic 
		transmission of the variant.
 
 Cases are also rising in parts of Europe but South America is the most 
		worrying region of the world for infections, with cases mounting in 
		nearly every country, the director of the Pan American Health 
		Organization (PAHO) said on Wednesday.
 
 SUSPENDING SHOTS
 
 Asia's increasing cases comes as worries are growing over the safety of 
		one of the most prominent vaccines aginst the virus.
 
 The European Medicines Agency on Wednesday said it found rare cases of 
		blood clots among some adult recipients of AstraZeneca Plc's COVID-19 
		vaccine, although it said the vaccine's advantages still outweighed the 
		risks.
 
		[to top of second column] | 
            
			 
            
			People walk at a crowded market amidst the spread of the coronavirus 
			disease (COVID-19), in the old quarters of Delhi, India, April 6, 
			2021. REUTERS/Anushree Fadnavis 
            
			 
		Both South Korea and the Philippines have suspended use of the vaccine 
		for people under 60 because of possible links to blood clots, while 
		Australia and Taiwan said they would continue to use it. 
            Worry about the vaccine could delay immunisation drives in Asia, 
			some of which are already dogged by supply problems. Campaigns in 
			most parts of Asia lag those in places like Britain and the United 
			States.
 Australia's programme to vaccinate its near 26 million people is 
			more than 80% behind its original schedule.
 
 Authorities there had pledged to administer at least 4 million first 
			doses by the end of March but could only deliver 670,000. The 
			government blamed supply issues from Europe.
 
 While India's cases mount, vaccine centres in several parts of the 
			country, including hardest-hit Maharashtra state, have been running 
			out of supplies.
 
 China, where the novel coronavirus emerged in late 2019, is driving 
			ahead with its vaccination campaign, administering about 3.68 
			million doses on Wednesday, taking its total number of doses given 
			to 149.07 million, authorities said.
 
 Japan's vaccinations are far behind those in most major economies, 
			with only one vaccine approved and about 1 million people having 
			received a first dose since February, even as it struggles with new 
			cases.
 
 Infections in Tokyo spiked by 545 cases on Thursday, adding to 
			worries about the Olympics and Paralympics, delayed from last year 
			and now due to start at the end of July.
 
 The government scrambled to calm a social media furore saying it was 
			not looking to prioritise vaccines for its Olympic athletes, 
			dismissing a media report that it was considering doing so.
 
             
            
 Japan is not insisting that arriving athletes be vaccinated but 
			there will be frequent tests while they are in Japan. There will be 
			no foreign spectators and a decision on domestic ones has yet to be 
			made.
 
 (Reporting by Reuters staff; Writing by Robert Birsel; Editing by 
			Simon Cameron-Moore)
 
 
			[© 2021 Thomson Reuters. All rights 
				reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |